Health canada authorizes moderna's covid-19 vaccine in children (6-11 years)

Announcement follows recent authorization of the company's mrna covid-19 vaccine in australia and the european union for active immunization to prevent covid-19 caused by sars-cov-2 in children aged 6-11 years. cambridge, ma / accesswire / march 17, 2022 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced that health canada has approved the use of moderna's mrna covid-19 vaccine, spikevax™, in a two-dose series of 50 Μg per dose for active immunization to prevent covid-19 caused by sars-cov-2 in children aged 6 to11 years.
MRNA Ratings Summary
MRNA Quant Ranking